Pascal Touchon - Aug 16, 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ John Chao, Attorney-in-Fact for Pascal Touchon
Stock symbol
ATRA
Transactions as of
Aug 16, 2024
Transactions value $
-$20,139
Form type
4
Date filed
8/20/2024, 06:27 PM
Previous filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$18.3K -2.76K -3.78% $6.63 70.4K Aug 16, 2024 Direct F1, F2, F3
transaction ATRA Common Stock Sale -$1.83K -276 -0.39% $6.63 70.1K Aug 16, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F3 This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024.